Director Obesity Vacancies in Novo Nordisk at Søborg, Capital Region, Denmark
Updated: March 05, 2024 06:43 AM GMT
Full time Job in Bagsvaerd, Capital Region of Denmark
Novo Nordisk
Søborg, DanemarkThis Job listing For Year 2022 is about Novo Nordisk in Søborg, Capital Region, Denmark
About the job
Head of Global Obesity Policy in Novo Nordisk Global Public Affairs
About The Department
Global Public Affairs is part of Novo Nordisk’s Corporate Strategy and Corporate Affairs (CSCA). In CSCA we help patients achieve better health by providing the best sustainable solutions across our triple bottom line. We are responsible for the global commercialisation of our products and for securing responsible business practices, effective communication and the building of strong relationships with key stakeholders.
Novo Nordisk is committed to be a sustainable business by creating long term value for our patients, employees, partners and shareholders through the development of innovative and competitive solutions which respond to unmet needs for our patients.
The Position
In this job you will be responsible for developing and driving our global obesity policy and strategy. You will... More Detail
Similar Jobs
Companies Hiring in Bagsvaerd, Capital Region of Denmark
Novo Nordisk
Novozymes
Lagkagehuset
Salling Group
Novo Nordisk
Q8 Danmark A/S
U.S. Embassy, Copenhagen - Denmark
Lidl Danmark
Novonesis
JYSK
NORMAL A/S
Velux A/S
Novo Nordisk
University of Copenhagen
DXC Technology
Novonesis
ReSound
New Jobs Posted in Bagsvaerd, Capital Region of Denmark
Latest Jobs in Bagsvaerd, Capital Region of Denmark
-
Analog IC Senior Manager
ReSound -
Department Assistant Talent Pipeline - Greater Copenhagen
Novo Nordisk A/S -
Process Manager for Quality Processes
Novo Nordisk -
Reparatør, Maintenance, Bagsværd
Novonesis -
Subject Matter Expert High Voltage Systems
Novo Nordisk A/S -
Senior Project Manager
DXC Technology -
医药代表-北京-GLP-1
Novo Nordisk -
Data Analyst
Novo Nordisk -
Ungarbejder til Q8 Bagsværd, 10 timer
Q8 Danmark A/S -
Laborantpraktikant til Novonesis med start 1. februar 2025
Novonesis